BrightViolet 450 Anti-Human HLA-DR Antibody[L243]

Human peripheral blood lymphocytes are stained with APC Anti-Human CD19 Antibody and BrightViolet 450 Anti-Human HLA-DR Antibody (Left). Lymphocytes are stained with APC Anti-Human CD19 Antibody and BrightViolet 450 Mouse IgG2a, κ Isotype Control (Right).

Human peripheral blood lymphocytes are stained with APC Anti-Human CD19 Antibody and BrightViolet 450 Anti-Human HLA-DR Antibody (Left). Lymphocytes are stained with APC Anti-Human CD19 Antibody and BrightViolet 450 Mouse IgG2a, κ Isotype Control (Right).

Catalog Number:MAB1111Q
Conjugate:BrightViolet 450
Size:100Tests
Concentration:5 μL/Test
Host:Mouse
Isotype:Mouse IgG2a, κ
Clone:Monoclonal
Reactivity:Human
Applications:Each lot of this antibody is quality control tested by flow cytometric analysis. <b style="color:#0070ca">The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood).</b> Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Form:Liquid
Synonyms:class II;DR beta;DR beta 1;DRB;DRB1;HLA-DR1B;HLA-DRB;HLA-DRB1;major histocompatibility complex;SS1

HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kD α (heavy) chain and a 27 kD β (light) chain. It is expressed on B cells, activated T cells, monocytes/macrophages, dendritic cells, and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells.

Applications

Each lot of this antibody is quality control tested by flow cytometric analysis. <b style="color:#0070ca">The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood).</b> Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.

Target Background

HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kD α (heavy) chain and a 27 kD β (light) chain. It is expressed on B cells, activated T cells, monocytes/macrophages, dendritic cells, and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells.

Synonyms:class II;DR beta;DR beta 1;DRB;DRB1;HLA-DR1B;HLA-DRB;HLA-DRB1;major histocompatibility complex;SS1

Storage

This product can be stored at 2-8°C for 24 months. Please protected from prolonged exposure to light and do not freeze.

Buffer

Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer.

Human peripheral blood lymphocytes are stained with APC Anti-Human CD19 Antibody and BrightViolet 450 Anti-Human HLA-DR Antibody (Left). Lymphocytes are stained with APC Anti-Human CD19 Antibody and BrightViolet 450 Mouse IgG2a, κ Isotype Control (Right).

No documents available.